600+ sources. One page. See who else covered it.
The Google Health app will notify users if there are signs their insulin resistance has shifted, at which point they may consider lifestyle changes or consult a physician.
We haven't written up this one. NDTV has the full story — the link below goes straight to it.
The cells undergo a classic form of plasticity previously thought to occur only in downstream visual circuits.
All three antibody-drug conjugate (ADC)-based anticancer new drug candidates being developed by Celltrion have been named targets for the Fast Track designation by the U.S.
Denmark’s Novo Nordisk, which has led the global pharmaceutical and biotech market on the back of explosive demand for the obesity treatments Wegovy and Ozempic, has run into an unexpected hurdle as…
About 90 per cent of the patients using MediSave at Regency Specialist Hospital in Johor Bahru are women, with maternity-related care among the most common treatments.
NeuroScientific has locked in a key meeting with the US FDA for its StemSmart technology aimed at treating refractory Crohn’s disease in a planned Phase 2 trial.